eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | ovarian hyperstimulation syndrome |
| Comorbidity | C0032460|polycystic ovary syndrome |
| Sentences | 7 |
| PubMedID- 21621772 | Objective: to evaluate the effectiveness of iv calcium infusion on prevention of ovarian hyperstimulation syndrome (ohss) in patients with polycystic ovary syndrome undergoing assisted reproductive techniques cycles. |
| PubMedID- 24564914 | Different promising strategies have been used to reduce the risk of ohss in patients with polycystic ovary syndrome (pcos) including ovarian stimulation using a gnrh-antagonist protocol followed by a gnrh-agonist ovulation trigger[1], low-dose stimulation protocol using highly purified follicle-stimulation hormone[2] and treatment segmentation with elective freezing of all oocytes or embryos[3]. |
| PubMedID- 22133908 | This systematic review and meta-analysis investigated whether gonadotrophin-releasing hormone (gnrh) antagonist protocols reduce the risk of ovarian hyperstimulation syndrome (ohss) in women with polycystic ovary syndrome undergoing ivf compared with the long agonist protocol. |
| PubMedID- 22563549 | Even though early-onset ohss occurs temporarily in patients with severe polycystic ovary syndrome, it disappears rapidly after oocyte retrieval owing to the short effect of gnrh agonist. |
| PubMedID- 21982727 | Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in vitro fertilization cycles: a randomized, controlled trial. |
| PubMedID- 25009730 | The target is to eliminate or significantly reduce the risk of ovarian hyperstimulation syndrome (ohss) in patients with polycystic ovary syndrome (pcos), drug cost and burden on patients. |
| PubMedID- 25242998 | In a meta-analysis performed by bayram et al, in order to compare the safety, effectiveness in terms of ovulation, pregnancy, miscarriage, multiple pregnancy rate and ovarian hyper-stimulation syndrome (ohss) in women with clomiphene-resistant polycystic ovary syndrome (pcos) who had used recombinant fsh or urinary fsh, four randomized trials were identified. |
Page: 1